Trademark: 97318073
Word
ALLUCENT CRO
Status
Pending
Status Code
730
Status Date
Tuesday, March 26, 2024
Serial Number
97318073
Mark Type
4
Filing Date
Thursday, March 17, 2022
Published for Opposition
Tuesday, August 1, 2023

Trademark Owner History

Classifications
41 Training and development in the field of conducting clinical trials, namely, conducting tutorials, seminars and workshops in the field of clinical trials; training in the field of computer software support, namely, conducting tutorials, seminars and workshops in the field of software support
9 Downloadable computer application software for use in connection with the collection, tracking, retrieval, validation, summarization, statistical analysis and presentation of data used in the areas of medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; downloadable computer application software for providing telehealth, telemedicine, remote care and virtual health care services to patients; downloadable computer application software for use in connection with collection, tracking, retrieval, validation, summarization, statistical analysis and presentation of remotely gathered patient-generated health data for use in clinical studies
35 Data management, namely, abstraction services in the nature of extracting and summarizing information from clinical trial records and collection of medical data from clinical tests and records for business purposes; Market research and business marketing consulting services in the pharmaceutical, biotechnology, medical device, and diagnostics industries; Data management, namely, the management for others of databases of patient health data
45 Development of regulatory compliance strategies in the field of medical research, namely, regulatory compliance consulting in the field of drug, biologic, cosmetic and medical device development
42 Cloud computing featuring software that allows users to collect, review, analyze and report on clinical research; technical support services, namely, installation and remote administration of software, and troubleshooting of software problems and hosted software applications, all for use in connection with medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; cloud computing featuring software for providing telehealth, telemedicine, remote care and virtual health care services to patients; cloud computing featuring software that allows users to collect, track, retrieve, validate, summarize, statistically analyze and present data used in the areas of medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; Cloud computing featuring software to aggregate, integrate, transfer and manage data generated from home health and remote monitoring devices and applications and health-related smart-phone applications; Cloud computing featuring software that provides integrated workflows, analytics, visualizations, and reporting features to deliver, process, analyze, elevate, and display patient-generated health data; Cloud computing featuring software that integrates remotely collected health data into databases, systems, platforms, applications, and software that inform clinical research, remote monitoring, and care management; technical consulting services, namely, evaluating the safety of pharmaceutical, medical, cosmetic and consumer devices and products in clinical development or in commercial production; Consulting services for others in the fields of design, planning, implementation and project management of clinical trials; Scientific analysis of statistical and qualitative data relating to clinical trials for pharmaceuticals, biotechnology, medical devices and diagnostics for scientific research and for the development of pharmaceutical, biotechnology, medical device and diagnostic products and methods of use of such devices and products

Trademark Events
Mar 21, 2022
New Application Entered
Mar 23, 2022
New Application Office Supplied Data Entered
Nov 21, 2022
Letter Of Protest Evidence Forwarded
Dec 28, 2022
Assigned To Examiner
Jan 4, 2023
Letter Of Protest Evidence Reviewed-No Further Action Taken
Jan 6, 2023
Non-Final Action Written
Jan 6, 2023
Non-Final Action E-Mailed
Jan 6, 2023
Notification Of Non-Final Action E-Mailed
Apr 6, 2023
Teas Response To Office Action Received
Apr 6, 2023
Correspondence Received In Law Office
Apr 6, 2023
Teas/Email Correspondence Entered
May 16, 2023
Final Refusal Written
May 16, 2023
Final Refusal E-Mailed
May 16, 2023
Notification Of Final Refusal Emailed
Jun 21, 2023
Teas Request For Reconsideration Received
Jun 21, 2023
Correspondence Received In Law Office
Jun 22, 2023
Teas/Email Correspondence Entered
Jun 29, 2023
Approved For Pub - Principal Register
Jul 12, 2023
Notification Of Notice Of Publication E-Mailed
Aug 1, 2023
Published For Opposition
Aug 1, 2023
Official Gazette Publication Confirmation E-Mailed
Sep 26, 2023
Noa E-Mailed - Sou Required From Applicant
Mar 26, 2024
Sou Extension 1 Filed
Mar 26, 2024
Sou Teas Extension Received
Mar 26, 2024
Sou Extension 1 Granted
Mar 27, 2024
Notice Of Approval Of Extension Request E-Mailed
Apr 4, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 4, 2024
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 4, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 4, 2024
Teas Change Of Correspondence Received
Apr 11, 2024
Teas Change Of Correspondence Received
Apr 11, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 11, 2024
Teas Change Of Owner Address Received

Trademark Alertz updated from USPTO on 2030-01-24